European journal of nuclear medicine and molecular imaging
Dual-tracer PET/CT with [68Ga]Ga-PSMA-617 and [68Ga]Ga-RM26 improves early prediction of biochemical failure in prostate cancer: a prospective phase II trial.
Jinhui Yang, Yujia Li, Yongxiang Tang, Bei Chen, Ling Xiao, Axel Rominger, Kuangyu Shi, Ming Zhou, Jian Li, Yi Cai, Tao Jiang, Shuo Hu
Published: 202510.1007/s00259-025-07574-8
Abstract
PURPOSE: Prostate-specific membrane antigen (PSMA) and Gastrin-releasing peptide receptor (GRPR) PET demonstrate hopeful results in initial staging of prostate cancer (PCa), offering potential to support precision treatment decisions. We investigated…
Preview only. Read the full abstract at the source